Microba Life Sciences Ltd (MAP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.287x

Based on the latest financial reports, Microba Life Sciences Ltd (MAP) has a cash flow conversion efficiency ratio of -0.287x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.34 Million ≈ $-6.61 Million USD) by net assets (AU$32.49 Million ≈ $22.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Microba Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Microba Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Microba Life Sciences Ltd carry for a breakdown of total debt and financial obligations.

Microba Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Microba Life Sciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
DLP Resources Inc V:DLP	-0.296x
Lipum AB ST:LIPUM	1.465x
FreeMs Corporation KQ:053160	0.004x
Wemade Max Co. Ltd KQ:101730	-0.016x
Korea SPAC 2 KQ:206400	-0.010x
Globus Maritime Ltd NASDAQ:GLBS	0.020x
Havila Shipping ASA OL:HAVI	0.404x
S Connect Co. LTD KQ:096630	0.027x

Annual Cash Flow Conversion Efficiency for Microba Life Sciences Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of Microba Life Sciences Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Microba Life Sciences Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$32.49 Million ≈ $22.99 Million	AU$-12.01 Million ≈ $-8.50 Million	-0.370x	+2.12%
2023-12-31	AU$41.22 Million ≈ $29.16 Million	AU$-15.57 Million ≈ $-11.01 Million	-0.378x	-18.01%
2022-12-31	AU$38.72 Million ≈ $27.40 Million	AU$-12.39 Million ≈ $-8.77 Million	-0.320x	-2.72%
2021-12-31	AU$33.54 Million ≈ $23.73 Million	AU$-10.45 Million ≈ $-7.39 Million	-0.312x	+35.20%
2020-12-31	AU$14.94 Million ≈ $10.57 Million	AU$-7.18 Million ≈ $-5.08 Million	-0.481x	+14.32%
2019-12-31	AU$7.70 Million ≈ $5.45 Million	AU$-4.32 Million ≈ $-3.06 Million	-0.561x	-94.62%
2018-12-31	AU$12.56 Million ≈ $8.88 Million	AU$-3.62 Million ≈ $-2.56 Million	-0.288x	--

About Microba Life Sciences Ltd

AU:MAP Australia Diagnostics & Research

Market Cap

$32.75 Million

AU$46.28 Million AUD

Market Cap Rank

#23427 Global

#926 in Australia

Share Price

AU$0.08

Change (1 day)

+8.57%

52-Week Range

AU$0.07 - AU$0.19

All Time High

AU$0.44